Ontrak, Inc. (OTRK)
USD 1.38
(-4.94%)
USD 1.38
(-4.94%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -20.67 Million USD | 52.12% |
| 2022 | -43.18 Million USD | -126.93% |
| 2021 | -19.02 Million USD | -27.51% |
| 2020 | -14.92 Million USD | 25.44% |
| 2019 | -20.01 Million USD | -46.89% |
| 2018 | -13.62 Million USD | -26.97% |
| 2017 | -10.73 Million USD | -63.23% |
| 2016 | -6.57 Million USD | 26.13% |
| 2015 | -8.89 Million USD | -56.51% |
| 2014 | -5.68 Million USD | 19.9% |
| 2013 | -7.09 Million USD | 25.75% |
| 2012 | -9.56 Million USD | 20.75% |
| 2011 | -12.06 Million USD | 10.45% |
| 2010 | -13.47 Million USD | 30.46% |
| 2009 | -19.37 Million USD | 63.86% |
| 2008 | -53.6 Million USD | -12.77% |
| 2007 | -47.53 Million USD | -19.05% |
| 2006 | -39.92 Million USD | -60.53% |
| 2005 | -24.87 Million USD | -108.22% |
| 2004 | -11.94 Million USD | -236.95% |
| 2003 | -3.54 Million USD | -916.13% |
| 2002 | -348.87 Thousand USD | -2724.28% |
| 2001 | 13.29 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -3.98 Million USD | 23.59% |
| 2024 Q2 | -4.04 Million USD | -1.61% |
| 2023 Q1 | -6.77 Million USD | 15.36% |
| 2023 Q3 | -4.06 Million USD | 12.19% |
| 2023 Q4 | -5.21 Million USD | -28.27% |
| 2023 FY | -20.67 Million USD | 52.12% |
| 2023 Q2 | -4.62 Million USD | 31.64% |
| 2022 Q1 | -13.14 Million USD | 26.9% |
| 2022 Q3 | -10.12 Million USD | 14.95% |
| 2022 Q4 | -7.99 Million USD | 21.03% |
| 2022 FY | -43.18 Million USD | -126.93% |
| 2022 Q2 | -11.91 Million USD | 9.4% |
| 2021 Q4 | -17.98 Million USD | -228.86% |
| 2021 Q1 | -2.88 Million USD | -57.89% |
| 2021 Q3 | -5.46 Million USD | -231.19% |
| 2021 FY | -19.02 Million USD | -27.51% |
| 2021 Q2 | -1.65 Million USD | 42.67% |
| 2020 Q4 | -1.82 Million USD | 39.36% |
| 2020 Q3 | -3 Million USD | 26.4% |
| 2020 Q2 | -4.08 Million USD | 31.93% |
| 2020 Q1 | -6 Million USD | 14.19% |
| 2020 FY | -14.92 Million USD | 25.44% |
| 2019 Q3 | -5.59 Million USD | -14.04% |
| 2019 FY | -20.01 Million USD | -46.89% |
| 2019 Q1 | -2.51 Million USD | -112.06% |
| 2019 Q2 | -4.9 Million USD | -95.11% |
| 2019 Q4 | -6.99 Million USD | -25.04% |
| 2018 Q3 | -4.04 Million USD | 2.36% |
| 2018 Q1 | -4.24 Million USD | -52.93% |
| 2018 FY | -13.62 Million USD | -26.97% |
| 2018 Q2 | -4.14 Million USD | 2.4% |
| 2018 Q4 | -1.18 Million USD | 70.69% |
| 2017 Q2 | -2.65 Million USD | -19.95% |
| 2017 FY | -10.73 Million USD | -63.23% |
| 2017 Q4 | -2.77 Million USD | 10.16% |
| 2017 Q3 | -3.09 Million USD | -16.55% |
| 2017 Q1 | -2.21 Million USD | -1679.29% |
| 2016 Q3 | -2.15 Million USD | -2.04% |
| 2016 FY | -6.57 Million USD | 26.13% |
| 2016 Q4 | 140 Thousand USD | 106.51% |
| 2016 Q2 | -2.1 Million USD | 14.25% |
| 2016 Q1 | -2.45 Million USD | -67.26% |
| 2015 FY | -8.89 Million USD | -56.51% |
| 2015 Q1 | -2.74 Million USD | -184.04% |
| 2015 Q2 | -2.5 Million USD | 8.46% |
| 2015 Q3 | -2.18 Million USD | 13.11% |
| 2015 Q4 | -1.46 Million USD | 32.61% |
| 2014 Q2 | -1.69 Million USD | -2.67% |
| 2014 FY | -5.68 Million USD | 19.9% |
| 2014 Q4 | -965 Thousand USD | 39.76% |
| 2014 Q3 | -1.6 Million USD | 5.32% |
| 2014 Q1 | -1.64 Million USD | 21.03% |
| 2013 FY | -7.09 Million USD | 25.75% |
| 2013 Q4 | -2.08 Million USD | -34.82% |
| 2013 Q1 | -1.74 Million USD | 22.79% |
| 2013 Q2 | -1.71 Million USD | 1.49% |
| 2013 Q3 | -1.54 Million USD | 9.95% |
| 2012 Q1 | -2.79 Million USD | 13.94% |
| 2012 FY | -9.56 Million USD | 20.75% |
| 2012 Q4 | -2.26 Million USD | -9.07% |
| 2012 Q3 | -2.07 Million USD | 14.84% |
| 2012 Q2 | -2.43 Million USD | 12.98% |
| 2011 Q2 | -3.08 Million USD | 2.81% |
| 2011 Q1 | -3.17 Million USD | 12.89% |
| 2011 FY | -12.06 Million USD | 10.45% |
| 2011 Q4 | -3.24 Million USD | -26.67% |
| 2011 Q3 | -2.56 Million USD | 16.75% |
| 2010 Q3 | -2.78 Million USD | 16.41% |
| 2010 Q1 | -3.72 Million USD | 9.47% |
| 2010 FY | -13.47 Million USD | 30.46% |
| 2010 Q2 | -3.32 Million USD | 10.78% |
| 2010 Q4 | -3.63 Million USD | -30.85% |
| 2009 Q4 | -4.11 Million USD | -4.25% |
| 2009 Q2 | -4.61 Million USD | 30.93% |
| 2009 Q3 | -3.95 Million USD | 14.44% |
| 2009 Q1 | -6.68 Million USD | 63.72% |
| 2009 FY | -19.37 Million USD | 63.86% |
| 2008 Q3 | -9.44 Million USD | 25.4% |
| 2008 Q2 | -12.65 Million USD | 3.17% |
| 2008 Q1 | -13.07 Million USD | -16.05% |
| 2008 FY | -53.6 Million USD | -12.77% |
| 2008 Q4 | -18.42 Million USD | -95.14% |
| 2007 Q2 | -12.02 Million USD | -11.59% |
| 2007 FY | -47.53 Million USD | -19.05% |
| 2007 Q4 | -11.26 Million USD | 16.38% |
| 2007 Q3 | -13.47 Million USD | -12.09% |
| 2007 Q1 | -10.77 Million USD | 3.09% |
| 2006 Q3 | -10.21 Million USD | -8.71% |
| 2006 Q1 | -9.2 Million USD | -4.95% |
| 2006 FY | -39.92 Million USD | -60.53% |
| 2006 Q4 | -11.11 Million USD | -8.85% |
| 2006 Q2 | -9.39 Million USD | -2.06% |
| 2005 Q1 | -4.48 Million USD | -34.37% |
| 2005 FY | -24.87 Million USD | -108.22% |
| 2005 Q4 | -8.77 Million USD | -29.81% |
| 2005 Q3 | -6.75 Million USD | -38.84% |
| 2005 Q2 | -4.86 Million USD | -8.62% |
| 2004 Q2 | -2.54 Million USD | 16.66% |
| 2004 FY | -11.94 Million USD | -236.95% |
| 2004 Q4 | -3.33 Million USD | -10.4% |
| 2004 Q3 | -3.02 Million USD | -18.8% |
| 2004 Q1 | -3.05 Million USD | -22.0% |
| 2003 Q3 | -844 Thousand USD | -319.9% |
| 2003 Q1 | -36.69 Thousand USD | 94.13% |
| 2003 Q2 | -201 Thousand USD | -447.7% |
| 2003 FY | -3.54 Million USD | -916.13% |
| 2003 Q4 | -2.5 Million USD | -196.21% |
| 2002 Q3 | -10.95 Thousand USD | -103.54% |
| 2002 Q4 | -624.75 Thousand USD | -5602.96% |
| 2002 Q1 | -22.37 Thousand USD | 0.0% |
| 2002 Q2 | 309.22 Thousand USD | 1481.75% |
| 2002 FY | -348.87 Thousand USD | -2724.28% |
| 2001 FY | 13.29 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CareCloud, Inc. | -47.11 Million USD | 56.118% |
| Augmedix, Inc. | -18.77 Million USD | -10.096% |
| BrightSpring Health Services, Inc. Common Stock | 147.18 Million USD | 114.047% |
| CareCloud, Inc. | -47.11 Million USD | 56.118% |
| HealthEquity, Inc. | 128.13 Million USD | 116.135% |
| iCoreConnect Inc. | -10.27 Million USD | -101.185% |
| Inovalon Holdings, Inc. | 71.71 Million USD | 128.831% |
| Nutex Health, Inc. | -31.77 Million USD | 34.931% |
| Omnicell, Inc. | -34.86 Million USD | 40.705% |
| OneMedNet Corporation | -8.37 Million USD | -146.888% |
| Progyny, Inc. | 62.18 Million USD | 133.248% |
| Renalytix Plc | -29.6 Million USD | 30.171% |
| Schrödinger, Inc. | -177.44 Million USD | 88.349% |
| Simulations Plus, Inc. | 6.13 Million USD | 437.221% |
| SOPHiA GENETICS SA | -74.82 Million USD | 72.369% |
| Streamline Health Solutions, Inc. | -19.64 Million USD | -5.232% |
| Ontrak, Inc. | -20.67 Million USD | -0.0% |
| GE HealthCare Technologies Inc. | 2.43 Billion USD | 100.849% |
| Sharecare, Inc. | -96.47 Million USD | 78.57% |
| Aclarion, Inc. | -4.87 Million USD | -324.017% |
| CareMax, Inc. | -656.15 Million USD | 96.849% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.36 Million USD | -285.187% |
| Forian Inc. | -5.59 Million USD | -269.526% |
| Bullfrog AI Holdings, Inc. Warrants | -5.36 Million USD | -285.187% |
| HeartBeam, Inc. | -15.31 Million USD | -35.007% |
| GeneDx Holdings Corp. | -163.66 Million USD | 87.367% |
| SCWorx Corp. | -1.45 Million USD | -1325.211% |
| Minerva Surgical, Inc. | -30.89 Million USD | 33.088% |
| Definitive Healthcare Corp. | -329.8 Million USD | 93.731% |
| 10x Genomics, Inc. | -265.32 Million USD | 92.208% |
| Zhongchao Inc. | -13.28 Million USD | -55.641% |
| Accolade, Inc. | -114.45 Million USD | 81.936% |
| MSP Recovery, Inc. | -559.87 Million USD | 96.307% |
| R1 RCM Inc. | 147.9 Million USD | 113.979% |
| Spok Holdings, Inc. | 21.22 Million USD | 197.395% |
| Privia Health Group, Inc. | 20.64 Million USD | 200.126% |
| EUDA Health Holdings Limited | -3.96 Million USD | -421.957% |
| TruBridge, Inc. | -42.6 Million USD | 51.472% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 147.18 Million USD | 114.047% |
| Sharecare, Inc. | -96.47 Million USD | 78.57% |
| Health Catalyst, Inc. | -126.89 Million USD | 83.707% |
| GoodRx Holdings, Inc. | -27 Million USD | 23.446% |
| Premier, Inc. | 157.08 Million USD | 113.161% |
| HealthStream, Inc. | 16.01 Million USD | 229.065% |
| Certara, Inc. | -40.77 Million USD | 49.294% |
| GeneDx Holdings Corp. | -163.66 Million USD | 87.367% |
| SHL Telemedicine Ltd. | -9 Million USD | -129.569% |
| CareCloud, Inc. | -47.11 Million USD | 56.118% |
| EUDA Health Holdings Limited | -3.96 Million USD | -421.957% |
| HeartBeam, Inc. | -15.31 Million USD | -35.007% |
| Mangoceuticals, Inc. | -9.21 Million USD | -124.268% |
| CareMax, Inc. | -656.15 Million USD | 96.849% |
| Healthcare Triangle, Inc. | -11.34 Million USD | -82.191% |
| National Research Corporation | 40.04 Million USD | 151.629% |
| Aclarion, Inc. | -4.87 Million USD | -324.017% |
| OptimizeRx Corporation | -26.4 Million USD | 21.691% |